TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Oncolytic and local immunotherapy

Original research

TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	248	258	97
Jun 2022	184	193	59
Jul 2022	109	111	26
Aug 2022	109	110	13
Sep 2022	100	103	18
Oct 2022	109	112	29
Nov 2022	88	88	24
Dec 2022	73	73	21
Jan 2023	50	50	14
Feb 2023	70	72	33
Mar 2023	39	40	22
Apr 2023	29	29	26
May 2023	30	32	18
Jun 2023	38	38	17
Jul 2023	18	18	14
Aug 2023	21	21	8
Sep 2023	23	25	11
Oct 2023	28	28	9
Nov 2023	32	32	14
Dec 2023	48	49	16
Jan 2024	23	23	13
Feb 2024	34	35	14
Mar 2024	34	34	44
Total	1537	1574	560